Exeter Collaboration for Academic Primary Care (APEx) Blog
Exeter Collaboration for Academic Primary Care (APEx) Blog
Dr Jo Butterworth previously shared news of securing aTeam Science Award | NIHR to support the Multiple Long-Term Conditions Cross-NIHR Collaboration | NIHR, bringing together an interdisciplinary team from across the UK to address important unanswered questions about care for people living with multiple long-term conditions (MLTC). The workstream (involving researchers, clinicians, methodologists, public contributors […]
What is Atrial Fibrillation and why does it matter? Atrial fibrillation (AF) is a common heart condition. It increases risk of developing other conditions, like heart failure, or having a stroke and dying early. For many people, AF can be frightening and confusing. People with AF often describe a constant daily balancing act between making […]
Caring for people with long-term conditions takes up substantial resources. This isnât news, but itâs surprising how much we still donât know. Itâs often simple stuff, that would really help us deliver care more effectively and efficiently. Work being undertaken by APEx academics in our Long-Term Conditions research theme is looking at some of these […]
A few members of the team following the IMPPP dissemination event at RCGP in October 2025 The research process can be a long one. Back in 2016, NIHRput a call out for evidence for interventions to improve the management ofpolypharmacy. By early in 2018, we had been awarded just under ÂŁ2 million byHSDR to develop, […]
Patient and public involvement (PPI) in research is about researchers and patients/public members working together in equal partnership to do research. PPI in health research is critical because it ensures that the research we do is relevant to and benefits those most impacted by the research. PPI for large programmes of work involving multiple studies […]
I was recently moaning about the fact that a colleague of mine is presenting the economic evaluation of our recent IMPPP clinical trial at the International Health Economics Association congress later this month. In Bali. Meanwhile, yours truly had to make do with a trip to Cardiff for this yearâs SAPC Annual Scientific Meeting. Clearly […]
When Prof Rupert Payne and I got our heads together to start writing our latest BJGP Editorial GLP-1 receptor agonists: panacea or affirmation of societal failure? It was difficult to know where to start. GLP-1 receptor agonists under the various brand names of Ozempic, Wegovy and Mounjaro have sky rocketed in use over recent years. […]
Associate Professor Christopher Clark We know how to lower blood pressure with drugs, and quite a lot about how health professionals can help people to treat their hypertension. (1) Evidence to support these interventions is well summarised in various international hypertension guidelines, which also reinforce lifestyle changes to lower blood pressure and reduce cardiovascular risk. […]
Iâve always enjoyed the regional SAPC conferences. Being very much at the smaller end of the conference spectrum, they are a great way to find out whatâs going on in the local region, and offer an opportunity for early career researchers in particular to present work in a friendly and relaxed environment. The 2025 meeting […]
Wow, it has been an amazing year, and my first full year as Director of APEx (Exeter Collaboration for Academic Primary Care). I wanted to take this opportunity to give an overview of the year in some numbers. And there have been so many achievements over the past 12 months, that I am not going […]